Similar to the results of our study, a small hospital-based study reported that antinuclear autoantibodies were more prevalent in DLBCL cases than in healthy controls [32], and a hospital-based study of antinuclear autoantibodies found that DLBCL patients were more likely to be positive for ANA, anti-Jo-1, anti-ssDNA, and perinuclear anti-neutrophil cytoplasmic antibody compared to NHL patients with other subtypes [33]. This evidence concerns the gene BTG3 and non-Hodgkin lymphoma.